Do vaccines still work during lymphoma treatment? new study aims to find out
NCT ID NCT06070961
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tracks 56 follicular lymphoma patients to see how long their COVID-19 and other vaccine immunity lasts while they receive chemotherapy and maintenance therapy. Researchers will collect blood samples at several time points to measure immune responses. The goal is to understand if vaccines remain effective during treatment, which could help improve vaccination strategies for these patients.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this study could help doctors understand how well vaccines protect follicular lymphoma patients during treatment, guiding future vaccination schedules.
What could go wrong
This is a small, observational study (56 participants) that only measures immune markers, not actual protection from infection. Results may not apply to all patients or treatments.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FOLLICULAR LYMPHOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
A.O. SS. Antonio e Biagio e Cesare Arrigo, S.C. Ematologia
Alessandria, IT, Italy
-
A.O.U. Città della Salute e della Scienza di Torino - S.C. Ematologia
Torino, IT, Italy
-
A.O.U. Città della Salute e della Scienza di Torino - S.C. Ematologia U
Torino, IT, Italy
-
A.O.U. Maggiore della Carità di Novara - S.C.D.U. Ematologia
Novara, IT, Italy
-
A.O.U. Senese - U.O.C. Ematologia
Siena, Italy
-
ASST Grande Ospedale Metropolitano Niguarda - SC Ematologia
Milan, IT, Italy
-
Azienda Ospedaliera S.Giuseppe Moscati - S.C. Ematologia e Trapianto emopoietico
Avellino, AV, 83100, Italy
-
Azienda Ospedaliera Universitaria Careggi - Unità funzionale di Ematologia
Florence, Italy
-
Azienda Unità Sanitaria Locale-IRCCS - Arcispedale Santa Maria Nuova - Ematologia
Reggio Emilia, Italy
-
IRCCS Policlinico San Matteo - Divisione di Ematologia
Pavia, IT, Italy
-
Nuovo Ospedale degli Infermi, SSD Ematologia
Biella, IT, Italy
-
Ospedale Guglielmo da Saliceto - U.O. Ematologia
Piacenza, IT, Italy
-
Ospedale Maggiore Policlinico Fondazione IRCCS Ca' Granda - Ematologia
Milan, IT, Italy
-
Ospedale delle Croci, Ematologia
Ravenna, RA, 48121, Italy